^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    gocatamig (MK-6070)

    i
    Associations
    News
    Trials
    Company:
    Daiichi Sankyo, Merck (MSD)
    Drug class:
    CD3 agonist, DLL3 inhibitor
    Related drugs:
    Associations
    News
    Trials